CASI
CASI is a Maryland-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer in Rockville.
Business Model:
Revenue: $37M
Employees: 51-200
Rankings
Industries / Tags:
Detailed CASI Information
Geographic Data
Address: 9620 Medical Center Drive
City: Rockville
State: MD
Zip: 20850
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$33M
Raised Total:$147M
Social
Metrics
3,675,457Website Global Rank
3,534Website Monthly Traffic
Twitter Followers
Description
CASI is a Maryland-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer in Rockville.
Contact Phone:
+12408642600
Contact Email:
CASI went public on 6/21/1996 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/21/1996
Ticker Symbol:
CASI
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2019 | Juventas | Series A | 0 |
| 7/2022 | Precision Autoimmune Therapeutics | Venture Round | 0 |
| 7/2022 | Precision Autoimmune Therapeutics | Venture Round | 0 |
| 7/2019 | Juventas | Series A | 0 |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2016 | Post-IPO Equity | 1 | - |
IDG Capital IDG Capital |
7/2020 | Private Placement | $38M | 9/2018 | Private Placement | $48.5M | 4/2020 | Debt | $350k |
U.S. Small Business Administration. |
3/2021 | Post-IPO Equity | $32.5M | 2/2010 | Post-IPO Equity | $2.5M | 3/2018 | Post-IPO Equity | 3 | $50M |
Robert W. Duggan ETP Fund IDG Capital IDG Capital Robert W. Duggan ETP Fund IDG Capital IDG Capital |
1/2012 | Post-IPO Equity | 2 | $10M |
Emerging Technology Partners Accel Emerging Technology Partners Accel |
10/2017 | Post-IPO Equity | $2.4M | 2/2006 | Post-IPO Equity | $30M | 9/2007 | Post-IPO Debt | 3 | $20M |
Oxford Finance LLC GE Healthcare Merrill Lynch GE Healthcare Oxford Finance LLC GE Healthcare Merrill Lynch GE Healthcare |
3/2016 | Post-IPO Equity | 1 | - |
IDG Capital IDG Capital |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 1/2006 | Miikana Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
